The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Self-efficacy: Toward a unifying theory of behavioral change
Bandura, A. (1978) · Advances in Behaviour Research and Therapy · doi:10.1016/0146-6402(78)90002-4 · Cited by 10,586
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Negative Self-Efficacy and Goal Effects Revisited
Bandura, A., & Locke, E. A. (2003) · Journal of Applied Psychology · doi:10.1037/0021-9010.88.1.87 · Cited by 2,813
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1×
“One of the objectives of the present paper is to reinforce the point so well argued by others (McLellan et al., 2000) that drug and alcohol dependence are, in fact, chronic relapsing disorders which share numerous characteristics with other chronic relapsing medical conditions such as hypertension,…”
BackgroundNeurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Inheritance of Alcohol Abuse: Cross-Fostering Analysis of Adopted Men
Cloninger, C. R. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780330019001 · Cited by 1,873
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Understanding and preventing relapse.
Brownell, K. D., Marlatt, G. A., Lichtenstein, E., & Wilson, G. T. (1986) · American Psychologist · doi:10.1037/0003-066x.41.7.765 · Cited by 895
Smith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892
Bale, T. L., Contarino, A., Smith, G. W., Chan, R., Gold, L. H., Sawchenko, P. E., Koob, G. F., Vale, W. W., & Lee, K.-F. (2000) · Nature Genetics · doi:10.1038/74263 · Cited by 849
Shank, R. P., Gardocki, J. F., Streeter, A. J., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02163.x · Cited by 810
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Stanley, B. G., & Leibowitz, S. F. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3940 · Cited by 741
Schoepp, D. D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 690
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123693.82339.fc · Cited by 654
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & Vivitrex Study Group, F. T. (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 635
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Animal Models of Alcoholism: Neurobiology of High Alcohol-Drinking Behavior in Rodents
McBride, W. J., & Li, T.-K. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i4.40 · Cited by 600
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption
Spanagel, R., Pendyala, G., Abarca, C., Zghoul, T., Sanchis-Segura, C., Magnone, M. C., Lascorz, J., Depner, M., Holzberg, D., Soyka, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1163 · Cited by 594 · cited 25×
“…possibility that the endocannabinoid system contributes to the hyperglutamatergic state which develops over the course of alcohol dependence (Dahchour & De Witte, 2003) and the glutamatemediated regulation of EtOH self-administration and relapse (Backstrom et al., 2004; Spanagel et al., 2005).”
BackgroundInfluentialOslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Voluntary consumption of ethanol in 15 inbred mouse strains
Belknap, J. K., Crabbe, J. C., & Young, E. R. (1993) · Psychopharmacology · doi:10.1007/bf02244901 · Cited by 556
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F., & Conquet, F. (2001) · Nature Neuroscience · doi:10.1038/nn0901-873 · Cited by 554
Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes, E. V., & Levin, F. R. (2004) · JAMA · doi:10.1001/jama.291.15.1887 · Cited by 532
Myrick, H., Anton, R. F., Li, X., Henderson, S., Drobes, D., Voronin, K., & George, M. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300295 · Cited by 521
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
Addolorato, G. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.504 · Cited by 481
Ethanol consumption and resistance are inversely related to neuropeptide Y levels
Thiele, T. E., Marsh, D. J., Ste. Marie, L., Bernstein, I. L., & Palmiter, R. D. (1998) · Nature · doi:10.1038/24614 · Cited by 468
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 419
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414
Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T. J., Bordnick, P. S., Ait-Daoud, N., & Hensler, J. (2000) · JAMA · doi:10.1001/jama.284.8.963 · Cited by 414
Naltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411
Hermans, E., & Challiss, R. A. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590465 · Cited by 404
Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.92 · Cited by 400
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387
Alcohol dependence and anxiety disorders: what is the relationship?
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1723 · Cited by 386
The Role of Glutamatergic Neurotransmission in the Pathophysiology of Alcoholism
Tsai, G., & Coyle, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.173 · Cited by 380
Kreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372
Mann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
(2001) · Survey of Anesthesiology · doi:10.1097/00132586-200108000-00061 · Cited by 360
Liu, X., & Weiss, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 359
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Heilig, M., McLeod, S., Brot, M., Heinrichs, S. C., Menzaghi, F., Koob, G. F., & Britton, K. T. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.35 · Cited by 356
Self-citationA missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 355
CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Excessive Ethanol Drinking Following a History of Dependence Animal Model of Allostasis
Roberts, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00167-0 · Cited by 349
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
Jenck, F., Moreau, J.-L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Nothacker, H.-P., & Civelli, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14854 · Cited by 347
Wang, L., Liu, J., Harvey-White, J., Zimmer, A., & Kunos, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336351100 · Cited by 340
Hungund, B. L., Szakall, I., Adam, A., Basavarajappa, B. S., & Vadasz, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01576.x · Cited by 334
Corticotropin-Releasing Factor*
YASUDA, N., GREER, M. A., & AIZAWA, T. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-123 · Cited by 323
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Self-citationReinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats
Lê, A. D., Quan, B., Juzytch, W., Fletcher, P. J., Joharchi, N., & Shaham, Y. (1998) · Psychopharmacology · doi:10.1007/s002130050498 · Cited by 319
Lê, A. D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000411 · Cited by 310
Ray, L. A., & Hutchison, K. E. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000148114.34000.b9 · Cited by 310
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
mu-Opioid receptor knockout mice do not self-administer alcohol.
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · PubMed · Cited by 303
Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W. W., & Lee, K.-F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00193.2002 · Cited by 293
Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes
Spanagel, R., & Zieglgänsberger, W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89800-8 · Cited by 291
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00174-4 · Cited by 274
Replication of the Stockholm Adoption Study of Alcoholism: Confirmatory Cross-Fostering Analysis
Sigvardsson, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080033007 · Cited by 267
Homayoun, H., Stefani, M. R., Adams, B. W., Tamagan, G. D., & Moghaddam, B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300417 · Cited by 252
Stress Enhancement of Craving During Sobriety: A Risk for Relapse
Breese, G. R., Chu, K., Dayas, C. V., Funk, D., Knapp, D. J., Koob, G. F., L??, D. A., O???Dell, L. E., Overstreet, D. H., Roberts, A. J., et al. (2005) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000153544.83656.3c · Cited by 250
mGluR5 Antagonist MPEP Reduces Ethanol-Seeking and Relapse Behavior
Bäckström, P., Bachteler, D., Koch, S., Hyytiä, P., & Spanagel, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300381 · Cited by 249
Zorrilla, E., Valdez, G., & Weiss, F. (2001) · Psychopharmacology · doi:10.1007/s002130100773 · Cited by 246
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Baptista, M. A. S., Martin-Fardon, R., & Weiss, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0176-04.2004 · Cited by 235
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ
Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12917-7 · Cited by 227
Bart, G., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300598 · Cited by 220
Self-citationEnhanced and Delayed Stress-Induced Alcohol Drinking in Mice Lacking Functional CRH1 Receptors
Sillaber, I., Rammes, G., Zimmermann, S., Mahal, B., Zieglgänsberger, W., Wurst, W., Holsboer, F., & Spanagel, R. (2002) · Science · doi:10.1126/science.1069836 · Cited by 220
Britton, K. T., Lee, G., Vale, W., Rivier, J., & Koob, G. F. (1986) · Brain Research · doi:10.1016/0006-8993(86)90539-1 · Cited by 217
Katner, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00084-0 · Cited by 217
Gryder, D. S., & Rogawski, M. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07069.2003 · Cited by 216
Review of the Use of Topiramate for Treatment of Bipolar Disorders
Suppes, T. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00010 · Cited by 215
Group II Metabotropic Glutamate Receptors Modulate Extracellular Glutamate in the Nucleus Accumbens
Xi, Z.-X., Baker, D. A., Shen, H., Carson, D. S., & Kalivas, P. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.162 · Cited by 212
Ability of Baclofen in Reducing Alcohol Intake and Withdrawal Severity: I???Preclinical Evidence
Colombo, G., Agabio, R., Carai, M. A. M., Lobina, C., Pani, M., Reali, R., Addolorato, G., & Gessa, G. L. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200001000-00010 · Cited by 208
Heinz, A., Lober, S., Georgi, A., Wrase, J., Hermann, D., Rey, E.-R., Wellek, S., & Mann, K. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg005 · Cited by 206
Ability of Baclofen in Reducing Alcohol Craving and Intake: II???Preliminary Clinical Evidence
Addolorato, G., Caputo, F., Capristo, E., Colombo, G., Gessa, G. L., & Gasbarrini, G. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200001000-00011 · Cited by 203
Effects of SR141716A on Ethanol and Sucrose Self-Administration
Freedland, C. S., Sharpe, A. L., Samson, H. H., & Porrino, L. J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200102000-00017 · Cited by 189
Alcohol and withdrawal: from animal research to clinical issues
De Witte, P., Pinto, E., Ansseau, M., & Verbanck, P. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00030-7 · Cited by 189
Valdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
A quantitative trait locus for alcohol consumption in selectively bred rat lines.
Carr, L. G., Foroud, T., Bice, P. J., Gobbett, T. A., Ivashina, J., Edenberg, H. J., Lumeng, L., & Li, T. (1998) · PubMed · Cited by 186
Hodge, C. W., Samson, H. H., & Chappelle, A. M. (1997) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04257.x · Cited by 185
Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence
Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., & Sobell, M. B. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00054.x · Cited by 185
Interactions between NPY and CRF in the amygdala to regulate emotionality
Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.006 · Cited by 183
Ehlers, C. L., Li, T.-K., Lumeng, L., Hwang, B. H., Somes, C., Jimenez, P., & Math??, A. A. (1998) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199811000-00022 · Cited by 179
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E. P., & Koob, G. F. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 176
Lappalainen, J., Kranzler, H. R., Malison, R., Price, L. H., Van Dyck, C., Rosenheck, R. A., Cramer, J., Southwick, S., Charney, D., Krystal, J., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.825 · Cited by 176
Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Ma, J. Z. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.905 · Cited by 173
Kuzmin, A., Sandin, J., Terenius, L., & Ögren, S. O. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041350 · Cited by 173
Neurobiology and clinical aspects of neuropeptide Y.
Heilig, M. A., & Widerlöv, E. (1995) · PubMed · Cited by 171
Self-citationNociceptin prevents stress-induced ethanol-but not cocaine-seeking behavior in rats
Martin-Fardon, R., Ciccocioppo, R., Massi, M., & Weiss, F. (2000) · NeuroReport · doi:10.1097/00001756-200006260-00026 · Cited by 168
The Effects of Adjunctive Topiramate on Cognitive Function in Patients with Epilepsy
Lee, S., Sziklas, V., Andermann, F., Farnham, S., Risse, G., Gustafson, M., Gates, J., Penovich, P., Al‐Asmi, A., Dubeau, F., et al. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.27402.x · Cited by 168
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167
Ciccocioppo, R., Economidou, D., Fedeli, A., Angeletti, S., Weiss, F., Heilig, M., & Massi, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1645-1 · Cited by 166
Self-citationPharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent
Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 162
Schroeder, J. P., Overstreet, D. H., & Hodge, C. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2175-9 · Cited by 161
Katner, S. N., & Weiss, F. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04070.x · Cited by 158
Voluntary Alcohol Consumption Is Controlled via the Neuropeptide Y Y1 Receptor
Thiele, T. E., Koh, M. T., & Pedrazzini, T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-j0006.2002 · Cited by 158
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
Murphy, N. P., Lee, Y., & Maidment, N. T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01425-0 · Cited by 158
Valdez, G. R., & Koob, G. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.020 · Cited by 157
Antagonism by alpha methyltyrosine of the ethanol‐induced stimulation and euphoria in man
Ahlénius, S., Carlsson, A., Engel, J. A., Svensson, T. H., & dersten, P. S. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973144part1586 · Cited by 155
Association of a CB1 Cannabinoid Receptor Gene (CNR1) polymorphism with severe alcohol dependence
Schmidt, L. G., Samochowiec, J., Finckh, U., Fiszer-Piosik, E., Horodnicki, J., Wendel, B., Rommelspacher, H., & Hoehe, M. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00164-8 · Cited by 154
Hodge, C. W., Miles, M. F., Sharko, A. C., Stevenson, R. A., Hillmann, J. R., Lepoutre, V., Besheer, J., & Schroeder, J. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0217-y · Cited by 153
McKay, J. R. (1999) · Journal of Studies on Alcohol · doi:10.15288/jsa.1999.60.566 · Cited by 152
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha-Poniewiera, A., Szewczyk, B., Tatarczynska, E., Chojnacka-Wójcik, E., & Wierońska, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00082-5 · Cited by 151
Vengeliene, V., Bachteler, D., Danysz, W., & Spanagel, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.002 · Cited by 150
Suppression of ethanol-induced locomotor stimulation by GABA-like drugs
Cott, J. M., Carlsson, A., Engel, J., & Lindqvist, M. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00505087 · Cited by 149
Basavarajappa, B. S., & Hungund, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720522.x · Cited by 145
Cippitelli, A., Bilbao, A., Hansson, A. C., del Arco, I., Sommer, W. H., Heilig, M. A., Massi, M., Bermúdez‐Silva, F. J., Navarro, M., Ciccocioppo, R., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04056.x · Cited by 144
Self-citationBasavarajappa, B. S., Cooper, T. B., & Hungund, B. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00175-9 · Cited by 140
Bachteler, D., Economidou, D., Danysz, W., Ciccocioppo, R., & Spanagel, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300657 · Cited by 136
Hwang, B. H., Zhang, J. K., Enters, C. L., Lumeng, L., & Li, T. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04220.x · Cited by 133
Badia‐Elder, N. E., Stewart, R. B., Powrozek, T. A., Roy, K. F., Murphy, J. M., & Li, T. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02225.x · Cited by 133
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Kaminski, R. M., Banerjee, M., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.010 · Cited by 129
Olive, M. F., McGeehan, A., Kinder, J. R., McMahon, T., Hodge, C. W., Janak, P. H., & Messing, R. O. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003319 · Cited by 128
Effects of Ondansetron in Early‐ Versus Late‐Onset Alcoholics: A Prospective, Open‐Label Study
Kranzler, H. R., Pierucci‐Lagha, A., Feinn, R., & Hernández–Ávila, C. A. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075547.77464.76 · Cited by 128
Harris, B. R., Prendergast, M., Gibson, D. A., Rogers, D. T., Blanchard, J. A., Holley, R. C., Fu, M. C., Hart, S. R., Pedigo, N. W., & Littleton, J. M. (2002) · PubMed · doi:10.1097/01.alc.0000042011.99580.98 · Cited by 124
Baclofen suppresses motivation to consume alcohol in rats
Colombo, G., Vacca, G., Serra, S., Brunetti, G., Carai, M. A. M., & Gessa, G. L. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1397-y · Cited by 122
Understanding US addiction physicians' low rate of naltrexone prescription
Mark, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00134-0 · Cited by 120
Cowen, M. S., Djouma, E., & Lawrence, A. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090449 · Cited by 120
Devine, D. P., Watson, S. J., & Akil, H. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00517-0 · Cited by 118
Linden, A.-M., Shannon, H. E., Baez, M., Yu, J., Koester, A., & Schoepp, D. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2098-x · Cited by 118
Kotecha, S. A., Jackson, M. F., Al‐Mahrouki, A., Roder, J., Orser, B. A., & MacDonald, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301946200 · Cited by 115
Heyser, C. J., Moc, K., & Koob, G. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300175 · Cited by 113
Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Javors, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1600 · Cited by 112
Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats
Colombo, G., Serra, S., Brunetti, G., Vacca, G., Carai, M. A. M., & Gessa, G. L. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00333-2 · Cited by 111
Ondansetron reduces the craving of biologically predisposed alcoholics
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Zanca, N. A., & Velázquez, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1002-9 · Cited by 109
Role of the Serotonergic System in the Neurobiology of Alcoholism: Implications for Treatment
Johnson, B. A. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00005 · Cited by 108
Gessa, G. L., Serra, S., VACCA, G., Carai, M. A. M., & Colombo, G. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh114 · Cited by 106
Colombo, G. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.499 · Cited by 103
de Fonseca, F. R., Roberts, A. J., Bilbao, A., Koob, G. F., & Navarro, M. (1999) · PubMed · Cited by 103
Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats
Ehlers, C. L., Chaplin, R. I., Wall, T. L., Lumeng, L., Li, T., Owens, M. J., & Nemeroff, C. B. (1992) · Psychopharmacology · doi:10.1007/bf02245418 · Cited by 100
GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats
Daoust, M., Saligaut, C., Lhuintre, J. P., Moore, N. D., Flipo, J., & BOISMARE, F. (1987) · Alcohol · doi:10.1016/0741-8329(87)90087-5 · Cited by 100
Tucker, J. A., Vuchinich, R. E., & Rippens, P. D. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.248 · Cited by 99
Harris, B. R., Gibson, D. A., Prendergast, M., Blanchard, J. A., Holley, R. C., Hart, S. R., Scotland, R. L., Foster, T. C., Pedigo, N. W., & Littleton, J. M. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000093601.33119.e3 · Cited by 98
Johnson, B. A., Campling, G. M., Griffiths, P., & Cowen, P. J. (1993) · Psychopharmacology · doi:10.1007/bf02247375 · Cited by 97
Genomic screen for QTLs underlying alcohol consumption in the P and NP rat lines
Bice, P. J., Foroud, T., Bo, R., & Castelluccio, P. (1998) · Mammalian Genome · doi:10.1007/s003359900905 · Cited by 94
Rimondini, R., Sommer, W. H., & Heilig, M. A. (2003) · Journal of Studies on Alcohol · doi:10.15288/jsa.2003.64.445 · Cited by 92
Self-citationTreating Alcohol and Drug Abuse – An Evidence Based Review
Berglund, P. D. M., Thelander, S., & Jonsson, P. D. E. (2003) · Wiley eBooks · doi:10.1002/3527601465.contrib · Cited by 89
Johnson, B. A., Ait‐Daoud, N., & Prihoda, T. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02048.x · Cited by 89
Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration
Kelley, S. P., Nannini, M. A., Bratt, A. M., & Hodge, C. W. (2001) · Peptides · doi:10.1016/s0196-9781(01)00361-8 · Cited by 88
Egli, M. (2005) · Addiction Biology · doi:10.1080/13556210500314550 · Cited by 88
Self-citationRimondini, R., Thorsell, A., & Heilig, M. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.084 · Cited by 87
Self-citationEffect of Baclofen on Alcohol and Sucrose Self-Administration in Rats
Anstrom, K. K., Cromwell, H. C., Markowski, T., & Woodward, D. J. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb04414.x · Cited by 86
Badia‐Elder, N. E., Stewart, R. B., Powrozek, T. A., Murphy, J. M., & Li, T. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000071929.17974.da · Cited by 86
Electrophysiological Actions of Neuropeptide Y and Its Analogs: New Measures for Anxiolytic Therapy?
Ehlers, C. L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00001-8 · Cited by 84
Thorsell, A., Slawecki, C. J., & Ehlers, C. L. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.01.016 · Cited by 84
Besheer, J., Lepoutre, V., & Hodge, C. W. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1769-3 · Cited by 83
Caberlotto, L., Thorsell, A., Rimondini, R., Sommer, W. H., Hyytiä, P., & Heilig, M. A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02162.x · Cited by 82
Self-citationEffects of Acamprosate on Excitatory Amino Acids During Multiple Ethanol Withdrawal Periods
Dahchour, A., & Witte, P. D. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000056617.68874.18 · Cited by 82
Richter, R. M., Zorrilla, E. P., Basso, A. M., Koob, G. F., & Weiss, F. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb01979.x · Cited by 82
Tomkins, D. M., Lê, A. D., & Sellers, E. M. (1995) · Psychopharmacology · doi:10.1007/bf02246222 · Cited by 81
Johnson, B. A. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000134533.96915.08 · Cited by 79
Olive, M. F., Mehmert, K. K., Koenig, H. N., Camarini, R., Kim, J. A., Nannini, M., Ou, C. J., & Hodge, C. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1248-2 · Cited by 78
Hodge, C. W., Chappelle, A. M., & Samson, H. H. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01709.x · Cited by 77
Gilpin, N. W., Stewart, R. B., Murphy, J. M., Li, T., & Badia‐Elder, N. E. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000065723.93234.1d · Cited by 76
Lodge, D. J., & Lawrence, A. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00793-5 · Cited by 76
Ait‐Daoud, N., Johnson, B. A., Prihoda, T. J., & Hargita, I. D. (2001) · Psychopharmacology · doi:10.1007/s002130000607 · Cited by 75
Ciccocioppo, R., Cippitelli, A., Economidou, D., Fedeli, A., & Massi, M. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.035 · Cited by 75
Mottagui‐Tabar, S., Prince, J. A., Wahlestedt, C., Zhu, G., Goldman, D. A., & Heilig, M. A. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000164365.04961.b1 · Cited by 75
Self-citationHerman, B. H., Frankenheim, J., Litten, R. Z., Sheridan, P. H., Weight, F. F., & Zukin, S. R. (2002) · Humana Press eBooks · doi:10.1385/1592593062 · Cited by 69
Cost-Minimization and the Number Needed to Treat in Uncomplicated Hypertension
Pearce, K. A., Furberg, C. D., Psaty, B. M., & Kirk, J. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00488-3 · Cited by 66
Lea, P. M., Movsesyan, V. A., & Faden, A. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706219 · Cited by 65
Increases in Sucrose Consumption, But Not Ethanol Consumption, Following ICV NPY Administration
Slawecki, C. J., Betancourt, M., Walpole, T., & Ehlers, C. L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00215-x · Cited by 61
The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat
Stromberg, M. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.006 · Cited by 61
Schroeder, J. P., Olive, M. F., Koenig, H. N., & Hodge, C. W. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000098875.95923.69 · Cited by 60
Malcolm, R. J., Herron, J. E., Anton, R. F., Roberts, J. W., & Moore, J. W. (2000) · Alcohol · doi:10.1016/s0741-8329(99)00073-7 · Cited by 57
Metabotropic glutamate 2/3 receptors as drug targets
Marek, G. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.003 · Cited by 55
Association of Neuropeptide Y Polymorphism With the Occurrence of Type 1 and Type 2 Alcoholism
Ilveskoski, E., Kajander, O. A., Lehtimäki, T. J., Kunnas, T. A., Karhunen, P. J., Heinälä, P., Virkkunen, M. E., & Alho, H. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02142.x · Cited by 54
Evolutionary underpinnings of excessive alcohol consumption
Gerald, M. S., & Higley, J. D. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00023.x · Cited by 53
Hayes, D. M., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000164375.16838.f3 · Cited by 52
Assessment of ethanol consumption and water drinking by NPY Y2 receptor knockout mice
Thiele, T. E., Naveilhan, P., & Ernfors, P. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.009 · Cited by 50
Hwang, B. H., Stewart, R. B., Zhang, J. K., Lumeng, L., & Li, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.042 · Cited by 49
Effects of Topiramate on Ethanol and Saccharin Consumption and Preferences in C57BL/6J Mice
Gabriel, K. I., & Cunningham, C. L. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150014.79657.64 · Cited by 48
Neuropeptide Y administration into the amygdala does not affect ethanol consumption
Katner, S. N., Slawecki, C. J., & Ehlers, C. L. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00235-5 · Cited by 45
Drugs for Relapse Prevention of Alcoholism
Spanagel, R., & Mann, K. F. (2005) · Birkhäuser Basel eBooks · doi:10.1007/b137043 · Cited by 44
Katner, S. N., Slawecki, C. J., & Ehlers, C. L. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0950-9 · Cited by 38
Palmer, A. A., Sharpe, A. L., Burkhart‐Kasch, S., McKinnon, C. S., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1896-5 · Cited by 38
Suzuki, R., Lumeng, L., McBride, W. J., Li, T., & Hwang, B. H. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.037 · Cited by 36
The Corticotropin-Releasing Factor/Urocortin System and Alcohol
Ryabinin, A. E., Bachtell, R. K., Heinrichs, S. C., Lee, S., RIVIER, C. L., Olive, M. F., Mehmert, K. K., Camarini, R., Kim, J. A., Koenig, H. N., et al. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02596.x · Cited by 36
Schroeder, J. P., Iller, K., & Hodge, C. W. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000098873.80433.ba · Cited by 34
Funk, D. R., Li, Z., Shaham, Y., & Lê, A. D. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.003 · Cited by 34
Murphy, B. C., Chiu, T., Harrison, M., Uddin, R. K., & Singh, S. M. (2002) · Biochemical Genetics · doi:10.1023/a:1020777528602 · Cited by 28
Ait‐Daoud, N., Johnson, B. A., Javors, M. A., Roache, J. D., & Zanca, N. A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02289.x · Cited by 27
Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation
Spranger, S., Rommel, B., Jauch, A. S., Bodammer, R., Mehl, B., & BULLERDIEK, J. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000717)93:2<117::aid-ajmg7>3.0.co;2-# · Cited by 23
Liu, X., & Weiss, F. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000134219.93192.00 · Cited by 22
Cited by
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.004 · Cited by 720
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
The clinical significance of drug craving
Tiffany, S. T., & Wray, J. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06298.x · Cited by 556
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503
Self-citation
Metadata
- Authors
- HEILIG, M., & EGLI, M.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 111
- Issue
- 3
- Pages
- 855-876
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2171098630
- Cited by
- 377
- References
- 208
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.